The recent years have witnessed major advances in the treatment of benign rare blood disorders such as hemophilia, sickle cell disease (SCD), and cold agglutinin disease (CAD).
Moreover, new guidelines have been developed for the diagnosis and management of these blood disorders. Clinicians including hematologists and emergency department physicians need to remain up to date on the various aspects of management of these hematological disorders to diagnose, treat, and manage associated complications. Moreover, access to novel therapies remains challenging due to payer restrictions including step therapy policies. Hematologists and their care team need education on streamlining the prior authorization processes to prevent treatment delays.
This CMEO Journal Club will equip HCPs with the latest evidence from recent clinical trials and scientific literature, enabling them to evaluate new prophylactic strategies and incorporate non-factor therapies into comprehensive, individualized treatment plans. Expert faculty will translate data into real-world insights to support improved patient outcomes and long-term disease management.
In this CMEO recorded webcast, expert faculty will present and discuss advances in non-factor therapies for hemophilia, including advancements in laboratory and monitoring practices and how to use shared decision-making (SDM) with patients to design individualized care plans that incorporate non-factor replacement therapies into treatment.
In this CME Outfitters recorded webcast, expert faculty will elucidate the importance of comprehensive therapeutic and supportive care in preventing end-organ damage and improving QoL in patients with SCD. Learners will be guided through determining the effectiveness and challenges of current therapies to address the burden of disease in patients with SCD. Faculty will discuss emerging options in SCD treatment, including the long-term efficacy and safety of new interventions and investigational agents.
In this 30-minute CME Outfitters Snack activity, two experts in hemophilia explore the reasons behind inequities in care. Indeed, non-White patients with hemophilia have the highest rates of mortality, chronic pain, impaired functional status, and hemophilia-related distress. Beyond illuminating the scope of the problem, the faculty provides several actionable strategies to help practicing clinicians ensure equitable care for all patients.
In this 30-minute CME Snack video, experts in hemophilia explore new and emerging therapies that can improve outcomes for patients with hemophilia. A case study presentation provides additional clinical perspective and offers ways to provide equitable treatment in underserved patient groups.
In this CME Outfitters podcast, expert faculty will review recent data and discuss the sweeping impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with multiple myeloma.
Supported by an educational grant from Novo Nordisk, Inc.
LocationFriday, April 5, 20246:00 AM CT
Sheraton Grand Chicago301 E North Water St, Chicago, IL 60611